Editorial: Next-generation PROTACs in oncology and beyond: exploring therapeutic targets and their degraders

Daiqing Liao; Debasish Bandyopadhyay

doi:10.3389/fphar.2026.1787837

Editorial: Next-generation PROTACs in oncology and beyond: exploring therapeutic targets and their degraders

Front Pharmacol. 2026 Jan 29:17:1787837. doi: 10.3389/fphar.2026.1787837. eCollection 2026.

Authors

Daiqing Liao^#¹, Debasish Bandyopadhyay^#²

Affiliations

¹ Department of Physiology and Aging, College of Medicine, and UF Health Cancer Institute, University of Florida, Gainesville, FL, United States.
² School of Integrative Biological and Chemical Sciences (SIBCS), University of Texas Rio Grande Valley, Edinburg, TX, United States.

^# Contributed equally.

No abstract available

Keywords: breast cancer; cancer immuno therapy; inflammation; peptide therapeutics; proteolysis-targeting chimeras (PROTACs); targeted protein degradation.

Publication types

Editorial